|
Oct 9
|
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges
|
|
Oct 3
|
Iridex Appoints Patrick Mercer as Chief Executive Officer
|
|
Jul 30
|
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
|
|
May 15
|
Q1 2024 IRIDEX Corp Earnings Call
|
|
May 15
|
IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
|
|
May 14
|
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 14
|
Iridex Reports First Quarter 2024 Financial Results
|
|
May 14
|
Even after rising 11% this past week, IRIDEX (NASDAQ:IRIX) shareholders are still down 59% over the past three years
|
|
May 8
|
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
|
|
Mar 27
|
IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript
|
|
Mar 27
|
Q4 2023 IRIDEX Corp Earnings Call
|
|
Mar 26
|
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 26
|
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 20
|
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
|
|
Jan 11
|
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
|
|
Nov 27
|
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
|